- REPORT SUMMARY
- TABLE OF CONTENTS
-
Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein.This protein has a key role in enhancing the immunogenic property of the polysaccharide.
These vaccines are mainly used to immunize infants and children against invasive disease caused by Hib bacteria, H. influenzae, Streptococcus pneumoniae, and Neisseria meningitidis. The increase in use of conjugate vaccines for adults, rise in number of regulatory approvals for conjugate vaccines, growth in prevalence of diseases caused by microorganisms such as Streptococcus pneumoniae and Neisseria meningitidis, and technological advancements majorly drive the growth of the market. In contrast, low accessibility to vaccines in remote areas and complex production procedure of conjugate vaccine restraint the market growth.
The report details the trend, potential and market size of Conjugate Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Conjugate Vaccinesmarket, defines the market attractiveness level of Conjugate Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Conjugate Vaccines industry, describes the types of Conjugate Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Conjugate Vaccines market and the development prospects and opportunities of Conjugate Vaccines industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Conjugate Vaccines market in Chapter 13.
By Player:
Sun Pharmaceutical Industries Ltd
Integrated Biotherapeutics Inc
Sanofi
Serum Institute of India Pvt Ltd
Mitsubishi Tanabe Pharma Corp
Merck & Co Inc
Pfenex Inc
GlaxoSmithKline Plc
Aurobindo Pharma Ltd
Pfizer Inc
By Type:
Multivalent Conjugate Vaccines
Monovalent Conjugate Vaccines
By End-User:
Baby
Adult
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Conjugate Vaccines Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Conjugate Vaccines Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Conjugate Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Conjugate Vaccines Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Conjugate Vaccines Market Analysis and Outlook to 2022
-
7.1 Global Conjugate Vaccines Consumption (2017-2022)
-
7.2 United States Conjugate Vaccines Consumption (2017-2022)
-
7.3 Europe Conjugate Vaccines Consumption (2017-2022)
-
7.4 China Conjugate Vaccines Consumption (2017-2022)
-
7.5 Japan Conjugate Vaccines Consumption (2017-2022)
-
7.6 India Conjugate Vaccines Consumption (2017-2022)
-
7.7 South Korea Conjugate Vaccines Consumption (2017-2022)
8 Region and Country-wise Conjugate Vaccines Market Analysis and Outlook to 2028
-
8.1 Global Conjugate Vaccines Consumption Forecast (2022-2028)
-
8.2 United States Conjugate Vaccines Consumption Forecast (2022-2028)
-
8.3 Europe Conjugate Vaccines Consumption Forecast (2022-2028)
-
8.4 China Conjugate Vaccines Consumption Forecast (2022-2028)
-
8.5 Japan Conjugate Vaccines Consumption Forecast (2022-2028)
-
8.6 India Conjugate Vaccines Consumption Forecast (2022-2028)
-
8.7 South Korea Conjugate Vaccines Consumption Forecast (2022-2028)
9 Global Conjugate Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global Conjugate Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Multivalent Conjugate Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Monovalent Conjugate Vaccines Consumption and Growth Rate (2017-2022)
-
9.2 Global Conjugate Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Baby Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Adult Consumption and Growth Rate (2017-2022)
10 Global Conjugate Vaccines Market Outlook by Types and Applications to 2028
-
10.1 Global Conjugate Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Multivalent Conjugate Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Monovalent Conjugate Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Conjugate Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Baby Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Adult Consumption Forecast and Growth Rate (2022-2028)
11 Global Conjugate Vaccines Import and Export Analysis (Top 5 Countries)
-
11.1 Global Conjugate Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Conjugate Vaccines Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Conjugate Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Conjugate Vaccines Market Competitive Analysis
-
14.1 Sun Pharmaceutical Industries Ltd
-
14.1.1 Sun Pharmaceutical Industries Ltd Company Details
-
14.1.2 Sun Pharmaceutical Industries Ltd Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sun Pharmaceutical Industries Ltd Conjugate Vaccines Product and Service
-
14.2 Integrated Biotherapeutics Inc
-
14.2.1 Integrated Biotherapeutics Inc Company Details
-
14.2.2 Integrated Biotherapeutics Inc Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Integrated Biotherapeutics Inc Conjugate Vaccines Product and Service
-
14.3 Sanofi
-
14.3.1 Sanofi Company Details
-
14.3.2 Sanofi Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi Conjugate Vaccines Product and Service
-
14.4 Serum Institute of India Pvt Ltd
-
14.4.1 Serum Institute of India Pvt Ltd Company Details
-
14.4.2 Serum Institute of India Pvt Ltd Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Serum Institute of India Pvt Ltd Conjugate Vaccines Product and Service
-
14.5 Mitsubishi Tanabe Pharma Corp
-
14.5.1 Mitsubishi Tanabe Pharma Corp Company Details
-
14.5.2 Mitsubishi Tanabe Pharma Corp Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Mitsubishi Tanabe Pharma Corp Conjugate Vaccines Product and Service
-
14.6 Merck & Co Inc
-
14.6.1 Merck & Co Inc Company Details
-
14.6.2 Merck & Co Inc Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck & Co Inc Conjugate Vaccines Product and Service
-
14.7 Pfenex Inc
-
14.7.1 Pfenex Inc Company Details
-
14.7.2 Pfenex Inc Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfenex Inc Conjugate Vaccines Product and Service
-
14.8 GlaxoSmithKline Plc
-
14.8.1 GlaxoSmithKline Plc Company Details
-
14.8.2 GlaxoSmithKline Plc Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GlaxoSmithKline Plc Conjugate Vaccines Product and Service
-
14.9 Aurobindo Pharma Ltd
-
14.9.1 Aurobindo Pharma Ltd Company Details
-
14.9.2 Aurobindo Pharma Ltd Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Aurobindo Pharma Ltd Conjugate Vaccines Product and Service
-
14.10 Pfizer Inc
-
14.10.1 Pfizer Inc Company Details
-
14.10.2 Pfizer Inc Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pfizer Inc Conjugate Vaccines Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Conjugate Vaccines
-
Figure Conjugate Vaccines Picture
-
Table Global Conjugate Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Conjugate Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Conjugate Vaccines Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Conjugate Vaccines Consumption by Country (2017-2022)
-
Figure United States Conjugate Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe Conjugate Vaccines Consumption and Growth Rate (2017-2022)
-
Figure China Conjugate Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan Conjugate Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India Conjugate Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Conjugate Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Conjugate Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States Conjugate Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Conjugate Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Conjugate Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Conjugate Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Conjugate Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Conjugate Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multivalent Conjugate Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Monovalent Conjugate Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Baby Consumption and Growth Rate (2017-2022)
-
Figure Global Adult Consumption and Growth Rate (2017-2022)
-
Figure Global Multivalent Conjugate Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monovalent Conjugate Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Baby Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Conjugate Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Conjugate Vaccines Export by Region (Top 5 Countries) (2017-2028)
-
Table Sun Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Industries Ltd Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Industries Ltd Conjugate Vaccines Product and Service
-
Table Integrated Biotherapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Integrated Biotherapeutics Inc Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Integrated Biotherapeutics Inc Conjugate Vaccines Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Conjugate Vaccines Product and Service
-
Table Serum Institute of India Pvt Ltd (Foundation Year, Company Profile and etc.)
-
Table Serum Institute of India Pvt Ltd Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Serum Institute of India Pvt Ltd Conjugate Vaccines Product and Service
-
Table Mitsubishi Tanabe Pharma Corp (Foundation Year, Company Profile and etc.)
-
Table Mitsubishi Tanabe Pharma Corp Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mitsubishi Tanabe Pharma Corp Conjugate Vaccines Product and Service
-
Table Merck & Co Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Inc Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Conjugate Vaccines Product and Service
-
Table Pfenex Inc (Foundation Year, Company Profile and etc.)
-
Table Pfenex Inc Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfenex Inc Conjugate Vaccines Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Conjugate Vaccines Product and Service
-
Table Aurobindo Pharma Ltd (Foundation Year, Company Profile and etc.)
-
Table Aurobindo Pharma Ltd Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Pharma Ltd Conjugate Vaccines Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Conjugate Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Conjugate Vaccines Product and Service
-

Chinese